Patent · US Active

Antagonists of IL-6

US8632774B2 · kind B2 · utility

16Cited by
9References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2009
Grant dateJan 21, 2014
Priority date
Expiry dateJul 2, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/468
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A binding domain polypeptide and fusion proteins thereof that recognize an IL6/IL6 receptor complex, as well as compositions and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.